From Biocompatibility to Immune Engineering

Abstract

Get full access to this article

View all access options for this article.

References

Homsy

. Bio-compatibility in selection of materials for implantation. J Biomed Mater Res 1970; 4: 341–356.

Williams

. The Williams dictionary of Biomaterials, Liverpool University Press: Liverpool, 1999.

FDA. Use of International Standard ISO-10993, ‘Biological Evaluation of Medical Devices Part 1: Evaluation and Testing' (Replaces #G87-1 #8294) (blue book memo). Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080735.htm (2014, accessed 3 May 2016).

Panicali

Davis

Weinberg

Paoletti

. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc Natl Acad Sci USA 1983; 80: 5364–5368.

Wendel

. Immunoengineering: a credible mechanism for CAMPATH-1H action in bone marrow and organ transplantation and the implications for treatment of the immune dysfunction AIDS. Med Hypotheses 2003; 60: 360–372.

Hale

Waldmann

. Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplant 1996; 17: 305–308.

CDC. CDC and Fort Dodge Animal Health Achieve First Licensed DNA Vaccine. Available at: http://web.archive.org/web/20070820194311/http:/www.cdc.gov/od/oc/media/pressrel/r050718.htm (2007, accessed 3 May 2016).

Appaiahgari

Vrati

. IMOJEV((R)): a Yellow fever virus-based novel Japanese encephalitis vaccine. Expert Rev Vaccines 2010; 9: 1371–1384.